Ponatinib vs. Imatinib as Frontline Treatment for Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia : A Matching Adjusted Indirect Comparison - Ribera, Jose-Maria (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Prawitz, Thibaud (Evidera Inc) ; Freitag, Andreas (Evidera Inc) ; Sharma, Anuj (Evidera Inc) ; Dobi, Balázs (Evidera Inc) ; Rizzo, Federica (Incyte Biosciences International Sàrl, Morges, Switzerland) ; Sabatelli, Lorenzo (Incyte Biosciences International Sàrl, Morges, Switzerland) ; Patos, Petros (Incyte Biosciences International Sàrl, Morges, Switzerland)
 
Comments (0) | Reviews (0)
Be the first to review this document.

Add review

Rate this article:
Give a title to your review:
Write your review:
Note: you have not defined your nickname.
N/D will be displayed as the author of this comment.